These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4588654)

  • 1. Chlamydospore-like cells in Candida albicans induced by 5-fluorocytosine.
    Lee WS
    Can J Microbiol; 1973 Nov; 19(11):1449-50. PubMed ID: 4588654
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparative in vitro study of amphotericin B 1 clotrimazole and 5-fluorocytosine against clinically isolated yeasts.
    Hamilton-Miller JM
    Sabouraudia; 1972 Nov; 10(3):276-83. PubMed ID: 4565443
    [No Abstract]   [Full Text] [Related]  

  • 3. Potentiation of rifampicin and 5-fluorocytosine as antifungal antibiotics by amphotericin B (yeast-membrane permeability-ribosomal RNA-eukaryotic cell-synergism).
    Medoff G; Kobayashi GS; Kwan CN; Schlessinger D; Venkov P
    Proc Natl Acad Sci U S A; 1972 Jan; 69(1):196-9. PubMed ID: 4550505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Candida albicans by amphotericin B in combination with 5-fluorocytosine.
    Beggs WH; Sarosi GA; Andrews FA
    Res Commun Chem Pathol Pharmacol; 1974 Jul; 8(3):559-62. PubMed ID: 4604617
    [No Abstract]   [Full Text] [Related]  

  • 5. Synergistic action of amphotericin B and 5-fluorocytosine against yeast-like organisms.
    Medoff G; Comfort M; Kobayashi GS
    Proc Soc Exp Biol Med; 1971 Nov; 138(2):571-4. PubMed ID: 5118468
    [No Abstract]   [Full Text] [Related]  

  • 6. Observations on 5-fluorocytosine and Candida albicans.
    Davies RR; Savage MA
    Sabouraudia; 1974 Nov; 12(3):302-8. PubMed ID: 4610822
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro susceptibility and resistance of Candida spp. to hamycin.
    Athar MA
    Sabouraudia; 1971 Nov; 9(3):256-62. PubMed ID: 4944203
    [No Abstract]   [Full Text] [Related]  

  • 8. A possible function of the chlamydospores of Candida albicans.
    Bakerspigel A; Burke S
    Mycopathol Mycol Appl; 1974 Oct; 54(1):147-52. PubMed ID: 4610380
    [No Abstract]   [Full Text] [Related]  

  • 9. Evidence for sequential action of amphotericin B and 5-fluorocytosine on Canida albicans ATCC 11651.
    Beggs WH; Andrews FA; Sarosi GA
    Res Commun Chem Pathol Pharmacol; 1977 Mar; 16(3):557-60. PubMed ID: 322227
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of 5-fluorocytosine and amphotericin B on Candida albicans infection in mice.
    Rabinovich S; Shaw BD; Bryant T; Donta ST
    J Infect Dis; 1974 Jul; 130(1):28-31. PubMed ID: 4601179
    [No Abstract]   [Full Text] [Related]  

  • 11. Nature and development of phenotypic resistance to amphotericin B in Candida albicans.
    Gale EF
    Adv Microb Physiol; 1986; 27():277-320. PubMed ID: 3532717
    [No Abstract]   [Full Text] [Related]  

  • 12. The porosity of the cell wall of Candida albicans.
    Cope JE
    J Gen Microbiol; 1980 Jul; 119(1):253-5. PubMed ID: 6997435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergism of amphotericin B and 5-fluorocytosine for candida species.
    Montgomerie JZ; Edwards JE; Guze LB
    J Infect Dis; 1975 Jul; 132(1):82-6. PubMed ID: 1097545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fungistatic activity, uptake and incorporation of 5-fluorocytosine in Candida albicans, as influenced by pyrimidines and purines. I. Reversal experiments.
    Polak A; Scholer HJ
    Pathol Microbiol (Basel); 1973; 39(2):148-59. PubMed ID: 4575668
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro sensitivity of Torulopsis glabrata to amphotericin B, 5-fluorocytosine, and clotrimazole (Bay 5097).
    Marks MI; Steer P; Eickhoff TC
    Appl Microbiol; 1971 Jul; 22(1):93-5. PubMed ID: 5165106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Candida by compounds which inhibit cholesterol biosynthesis. Effects on strains sensitive and resistant to polyenes.
    Hamilton-Miller JM
    Chemotherapy; 1973; 18(3):154-61. PubMed ID: 4567768
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro susceptibility of Cryptococcus neoformans to amphotericin B, hamycin, and 5-fluorocytosine.
    Shadomy S; Shadomy HJ; McCay JA; Utz JP
    Antimicrob Agents Chemother (Bethesda); 1968; 8():452-60. PubMed ID: 5735392
    [No Abstract]   [Full Text] [Related]  

  • 18. Strong correlation between the antifungal effect of amphotericin B and its inhibitory action on germ-tube formation in a Candida albicans URA⁺ strain.
    Guirao-Abad JP; González-Párraga P; Argüelles JC
    Int Microbiol; 2015 Mar; 18(1):25-31. PubMed ID: 26415664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic resistance to miconazole and amphotericin B in Candida albicans.
    Gale EF; Johnson AM; Kerridge D; Wayman F
    J Gen Microbiol; 1980 Apr; 117(2):535-8. PubMed ID: 6999120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined in vitro activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans and Candida albicans.
    Chen HH; Liushih RN; Hsieh WC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1982 May; 15(2):106-12. PubMed ID: 7047097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.